|
Market Closed -
Australian S.E.
05:10:07 20/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.645 AUD | +0.92% |
|
-10.35% | -0.60% |
| 11-13 | PYC Therapeutics Enrolls First 24 Patients in Kidney Disease Trial; Shares Fall 3% | MT |
| 11-12 | PYC Therapeutics Limited - Shareholder/Analyst Call |
Chart: Technical Analysis
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PYC | Delayed | |
| PYCXF | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1.8 | 2.91 | 2.82 |
| Spread/Res. | -8.61% | -43.47% | -41.67% |
| Spread/Supp. | +0.92% | +41.81% | +49.55% |
| Support | 1.63 | 1.16 | 1.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PYC Stock
- Charts PYC Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
















